Paper10437367
[Alpha 1-protease inhibitor deficiency. Diagnosis, follow-up and therapy options].
Köhnlein T and 2 others. Med Klin (Munich), 1999. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. [Alpha 1-protease inhibitor deficiency. Diagnosis, follow-up and therapy options]. Papers, record 10437367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10437367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| alpha 1-Antitrypsin Deficiency | Major topic |
| Adult | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Lung Diseases, Obstructive | |
| Male | |
| Middle Aged | |
| Phenotype | |
| Pulmonary Emphysema | |
| alpha 1-Antitrypsin |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9157439 | [Proteinase/antiproteinase balance in patients with cystic fibrosis]. | Pneumologie | 1996 | https://conductscience.org/library/papers/9157439 | PubMed |
| 2 | 2191843 | [Long-term substitution in homozygous alpha 1-antitrypsin deficiency. Effect of the proteinase-antiproteinase equilibrium in plasma and sputum]. | Dtsch Med Wochenschr | 1990 | https://conductscience.org/library/papers/2191843 | PubMed |
| 3 | 8181327 | Replacement therapy for hereditary alpha1-antitrypsin deficiency. A program for long-term administration. | Chest | 1994 | https://conductscience.org/library/papers/8181327 | PubMed |
| 4 | 9552014 | The value of antibiotics and the outcomes of antibiotic therapy in exacerbations of COPD. | Chest | 1998 | https://conductscience.org/library/papers/9552014 | PubMed |
| 5 | 7784713 | Preliminary evidence that augmentation therapy diminishes degradation of cross-linked elastin in alpha-1-antitrypsin-deficient humans. | Respiration | 1995 | https://conductscience.org/library/papers/7784713 | PubMed |
| 6 | 9387938 | Alpha-1-antitrypsin replacement therapy: will its efficacy ever be proved? | Eur Respir J | 1997 | https://conductscience.org/library/papers/9387938 | PubMed |
| 7 | 3494198 | Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema. | N Engl J Med | 1987 | https://conductscience.org/library/papers/3494198 | PubMed |
| 8 | 7489808 | Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. | Eur Respir J | 1995 | https://conductscience.org/library/papers/7489808 | PubMed |
| 9 | 9655709 | Lung volume reduction surgery has variable effects on blood gases in patients with emphysema. | Am J Respir Crit Care Med | 1998 | https://conductscience.org/library/papers/9655709 | PubMed |
| 10 | 3492164 | Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. | Ann Intern Med | 1987 | https://conductscience.org/library/papers/3492164 | PubMed |
| 11 | 9556728 | [Acute dyspnea]. | Internist (Berl) | 1998 | https://conductscience.org/library/papers/9556728 | PubMed |
| 12 | 9387950 | Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group. | Eur Respir J | 1997 | https://conductscience.org/library/papers/9387950 | PubMed |
| 13 | 9655706 | Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study Group. | Am J Respir Crit Care Med | 1998 | https://conductscience.org/library/papers/9655706 | PubMed |
| 14 | 3493719 | Comparison of alpha-1-antitrypsin levels and antineutrophil elastase capacity of blood and lung in a patient with the alpha-1-antitrypsin phenotype null-null before and during alpha-1-antitrypsin augmentation therapy. | Am Rev Respir Dis | 1987 | https://conductscience.org/library/papers/3493719 | PubMed |
| 15 | 8694645 | The current status of lung volume reduction operations for emphysema. | Ann Thorac Surg | 1996 | https://conductscience.org/library/papers/8694645 | PubMed |
| 16 | 316188 | Cigarette smoking induces functional antiprotease deficiency in the lower respiratory tract of humans. | Science | 1979 | https://conductscience.org/library/papers/316188 | PubMed |
| 17 | 7907437 | What role for theophylline? | Thorax | 1994 | https://conductscience.org/library/papers/7907437 | PubMed |
| 18 | 3485248 | Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency. | N Engl J Med | 1986 | https://conductscience.org/library/papers/3485248 | PubMed |
| 19 | 1083485 | Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. | N Engl J Med | 1976 | https://conductscience.org/library/papers/1083485 | PubMed |
| 20 | 2787611 | Anti-neutrophil-elastase defenses of the lower respiratory tract in alpha 1-antitrypsin deficiency directly augmented with an aerosol of alpha 1-antitrypsin. | Ann Intern Med | 1989 | https://conductscience.org/library/papers/2787611 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SERPINA1 | 5265 | PubTator's text mining | https://conductscience.org/library/genes/5265 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10437367
GET https://conductscience.org/api/papers/v1/10437367/references?page=2